← Back to Search

Dietary Supplement

Study Drinks for Detoxification in Healthy Subjects

Phase 2
Waitlist Available
Led By Stephen Hecht, PhD
Research Sponsored by Masonic Cancer Center, University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights

Study Summary

This trial is testing if a study drink can help remove environmental toxins and cancer-causing agents from the body, especially in people who lack certain detoxification genes. If successful, the drink could be a cheap way to help improve health.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effect of study drink Preparation on carcinogens
Effect of study drink Preparation on toxins

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Freeze Dried Powder PreparationExperimental Treatment2 Interventions
Group II: PlaceboPlacebo Group2 Interventions

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,317 Total Patients Enrolled
Masonic Cancer Center, University of MinnesotaLead Sponsor
271 Previous Clinical Trials
14,275 Total Patients Enrolled
Stephen Hecht, PhDPrincipal InvestigatorDepartment of Laboratory Medicine and Pathology, University of Minnesota

Media Library

Freeze dried Powder (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT03978117 — Phase 2
Healthy Subjects Research Study Groups: Placebo, Freeze Dried Powder Preparation
Healthy Subjects Clinical Trial 2023: Freeze dried Powder Highlights & Side Effects. Trial Name: NCT03978117 — Phase 2
Freeze dried Powder (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03978117 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there any potential danger associated with Freeze dried Powder for patients?

"Due to the Phase 2 clinical trial status, our team has assigned Freeze Dried Powder a safety score of two as there is evidence testifying to its lack of toxicity but no data indicating any therapeutic effects."

Answered by AI

Does this medical experiment currently require volunteers?

"Affirmative. According to clinicaltrials.gov, this research initiative is currently recruiting patients who were initially posted on February 18th of 2021 and was last updated April 4th 2022. 350 participants are needed for the trial which will be conducted at one location."

Answered by AI

Are there any limitations to the amount of volunteers for this experiment?

"Affirmative. Clinicaltrials.gov has confirmed that the medical research project, which was first posted on February 18th 2021 is still enrolling participants. 350 individuals are needed from one medical site for this study to reach completion."

Answered by AI

Who else is applying?

What state do they live in?
Minnesota
What site did they apply to?
University of Minnesota
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria

How responsive is this trial?

Typically responds via
Phone Call
Email
Average response time
  • < 1 Day
Most responsive sites:
  1. University of Minnesota: < 24 hours
~84 spots leftby Apr 2025